Reply

This study was conducted because we were concerned about the absence of data on PTIF even though it at least partly determines the effectiveness of the first-line treatment most often chosen for AVB management (ie, high-flow nasal cannula oxygen therapy [HFNC]). Indeed, measurements have been recorded in very preterm or healthy full-term neonates but none in patients with AVB.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Letters to the Editor Source Type: research